Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Advaxis Inc (ADXS)  
$0.06 0.00 (0.00%) as of 4:30 Fri 6/3


Download
   
Exchange: OTC Bulletin Board
Security Type: Common
Shares Out: 66,230,000
Market Cap: 4.11(M)
Last Volume: 362,100 Avg Vol: 361,103
52 Week Range: $0.062 - $0.062
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Advaxis is a clinical-stage biotechnology company focused on the development and commercialization of proprietary Listeria monocytogenes (Lm) Technology antigen delivery products based on a platform technology that utilizes live attenuated Lm bioengineered to secrete antigen/adjuvant fusion proteins. Co.'s pipeline of product candidates include: ADXS-503, which is for the cancer indication of non-small cell lung cancer in combination with KEYTRUDA® (pembrolizumab); ADXS-504, which is for the cancer indication of early stage prostate cancer; and ADXS-PSA, which is for the cancer indication of metastatic prostate cancer in combination with KEYTRUDA® (pembrolizumab).

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 1,317,716 1,317,716
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-18 2023-11-17 2023-05-19 2022-05-19

   
Records found: 586
  Page 18 of 24  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Bonstein Sara Chief Financial Officer   •       –      –    2014-08-01 4 D $2.84 $406 D/D (143) 84,597     -
   Bonstein Sara Chief Financial Officer   •       –      –    2014-08-01 4 A $2.84 $1,945 D/D 685 84,740     -
   Mayes Gregory T. Chief Operating Officer   •       –      –    2014-08-01 4 D $2.84 $315 D/D (111) 134,990     -
   Mayes Gregory T. Chief Operating Officer   •       –      –    2014-08-01 4 A $2.84 $2,292 D/D 807 135,101     -
   French Christy Lee VP-Regulatory, Medical Affairs   •       –      –    2014-08-01 4 D $2.84 $8,051 D/D (2,011) 73,005     -
   French Christy Lee VP-Regulatory, Medical Affairs   •       –      –    2014-08-01 4 A $2.84 $1,204 D/D 424 73,050     -
   O'connor Daniel Chief Executive Officer   •       •      –    2014-08-01 4 D $2.84 $34,018 D/D (8,699) 296,439     -
   O'connor Daniel Chief Executive Officer   •       •      –    2014-08-01 4 A $2.84 $9,375 D/D 3,301 297,312     -
   Appel Roni Director   –       •      –    2014-07-17 4 A $0.00 $0 D/D 50,000 117,331     -
   Bonstein Sara Chief Financial Officer   •       –      –    2014-07-17 4 D $5.07 $86,438 D/D (17,049) 84,055     -
   Bonstein Sara Chief Financial Officer   •       –      –    2014-07-17 4 A $0.00 $0 D/D 100,000 101,104     -
   Sidransky David Director   –       •      –    2014-07-17 4 A $0.00 $0 D/D 50,000 60,304     -
   Patton James P Director   –       •      –    2014-07-17 4 A $0.00 $0 D/D 50,000 158,528     -
   Mckearn Thomas J Director   –       •      –    2014-07-17 4 A $0.00 $0 D/D 50,000 73,529     -
   Berman Richard J Director   –       •      –    2014-07-17 4 A $0.00 $0 D/D 50,000 50,000     -
   Moore Thomas A Former Director   –       –      –    2014-07-17 4 A $0.00 $0 D/D 10,976 176,462     -
   French Christy Lee VP-Regulatory, Medical Affairs   •       –      –    2014-07-17 4 D $4.03 $18,175 D/D (4,510) 74,592     -
   Petit Robert Chief Scientific Officer   •       –      –    2014-07-17 4 D $4.03 $22,487 D/D (5,580) 114,303     -
   O'connor Daniel Chief Executive Officer   •       •      –    2014-07-17 4 D $4.03 $66,366 D/D (16,468) 301,837     -
   O'connor Daniel Chief Executive Officer   •       •      –    2014-07-01 4 D $3.15 $3,774 D/D (1,198) 318,305     -
   O'connor Daniel Chief Executive Officer   •       •      –    2014-07-01 4 A $0.00 $0 D/D 3,968 319,503     -
   Mayes Gregory T. Chief Operating Officer   •       –      –    2014-07-01 4 D $3.15 $466 D/D (148) 134,294     -
   Mayes Gregory T. Chief Operating Officer   •       –      –    2014-07-01 4 A $0.00 $0 D/D 971 134,442     -
   Bonstein Sara Chief Financial Officer   •       •      –    2014-07-01 4 D $3.15 $762 D/D (242) 1,104     -
   Bonstein Sara Chief Financial Officer   •       •      –    2014-07-01 4 A $0.00 $0 D/D 824 1,346     -
  586 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 18 of 24
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us